197 related articles for article (PubMed ID: 16171044)
1. [A challenge].
Krankenpfl J; 2005; 43(4-6):93. PubMed ID: 16171044
[No Abstract] [Full Text] [Related]
2. [Duloxetine (Yentreve) in the general practice test: recommendation by the experts. Effective and tolerable therapy of symptoms in female stress incontinence].
Krankenpfl J; 2005; 43(7-10):189-90. PubMed ID: 16515261
[No Abstract] [Full Text] [Related]
3. [Stress incontinence in general practice].
Krankenpfl J; 2004; 42(7-10):228-9. PubMed ID: 15675390
[No Abstract] [Full Text] [Related]
4. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
5. [Successful phase III study with serotonin-noradrenaline reuptake inhibitor. Soon a drug to control stress incontinence].
MMW Fortschr Med; 2004 Feb; 146(7):59. PubMed ID: 15347056
[No Abstract] [Full Text] [Related]
6. Mixed incontinence.
Wein AJ
J Urol; 2005 Jun; 173(6):2055-7. PubMed ID: 15879826
[No Abstract] [Full Text] [Related]
7. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
8. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
[TBL] [Abstract][Full Text] [Related]
10. [The 10-minute consultation. Urinary incontinence in a woman].
Kolben M; Maurer S; Knitza R
MMW Fortschr Med; 2004 Jul; 146(29-30):59-60. PubMed ID: 15540565
[No Abstract] [Full Text] [Related]
11. Pharmacologic treatment of stress urinary incontinence: expectations for outcome.
Schuessler B; Baessler K
Urology; 2003 Oct; 62(4 Suppl 1):31-8. PubMed ID: 14550835
[TBL] [Abstract][Full Text] [Related]
12. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine: a new approach for treating stress urinary incontinence.
Moore K
Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological treatment for stress urinary incontinence in prostate cancer].
Puyol M; Collado A
Arch Esp Urol; 2009 Dec; 62(10):882-8. PubMed ID: 20068265
[TBL] [Abstract][Full Text] [Related]
16. The use of Duloxetine in the treatment of male stress urinary incontinence.
Fink KG; Huber J; Würnschimmel E; Schmeller NT
Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
[TBL] [Abstract][Full Text] [Related]
17. New developments in the management of stress urinary incontinence.
Cardozo L
BJU Int; 2004 Jul; 94 Suppl 1():1-3. PubMed ID: 15139856
[No Abstract] [Full Text] [Related]
18. Innovations in pharmacotherapy for stress urinary incontinence.
Cannon TW; Yoshimura N; Chancellor MB
Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):367-72. PubMed ID: 14676995
[TBL] [Abstract][Full Text] [Related]
19. [Update on medical treatment of female stress urinary incontinence].
Yazbeck C; Dhainaut C; Batallan A; Thoury A; Madelenat P
Gynecol Obstet Fertil; 2004 Jun; 32(6):556-61. PubMed ID: 15217571
[TBL] [Abstract][Full Text] [Related]
20. Neurobiology of stress urinary incontinence: new insights and implications for treatment.
Cardozo L
J Obstet Gynaecol; 2005 Aug; 25(6):539-43. PubMed ID: 16234136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
